Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Centre of technological excellence to be built in the EU?:

This article was originally published in Clinica

Executive Summary

European Commission president Jose Manuel Barroso has put forward a proposal to set up an EU institute of technology, a centre of excellence along the lines of the highly successful US Massachusetts Institute of Technology (MIT), which houses 900 faculty members and 10,000 students. This would be a key initiative in helping the EU reach its target spending of 3% of GDP on research and development from its current level of 2% and align its investment levels with those of the US. The MIT, which receives over two-thirds of its funding from the US government and approximately 20% from private investors, is focusing on research areas including bio-engineering and neuroscience. Mr Barroso believes that an EU counterpart would "act as a pole of attraction for the very best minds, ideas and companies around the world". There are proposals, should the institute get the go-ahead, that it should be based in one of the new member states.

Topics

UsernamePublicRestriction

Register

MT054315

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel